Welcome to our dedicated page for Northview Acquisition SEC filings (Ticker: NVACR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings page for NorthView Acquisition Corp. Rights (NVACR) provides access to regulatory documents filed by NorthView Acquisition Corp., the SPAC that issued these rights. NorthView’s securities, including its common stock, rights and warrants, are registered under Section 12(b) of the Exchange Act, and the company files reports and current disclosures with the U.S. Securities and Exchange Commission.
Among the filings relevant to NVACR holders are registration statements and prospectuses describing the initial public offering of units, where each unit consisted of one share of common stock, one right and one-half of one redeemable warrant. These documents explain that each right entitles the holder to receive one-tenth of one share of common stock upon consummation of an initial business combination. They also outline the terms of the warrants and the conditions under which the securities trade separately on the Nasdaq Global Market.
Current reports on Form 8-K are another important category. For example, an 8-K details an amendment to NorthView’s Certificate of Incorporation extending the date by which the company must complete a business combination or, failing that, cease operations and redeem or repurchase 100% of the shares issued in its initial public offering. That filing confirms that the rights, each entitling the holder to receive one-tenth of one share of common stock, trade under the symbol NVACR and identifies NorthView as an emerging growth company incorporated in Delaware.
Filings related to the proposed business combination with Profusa, Inc., including a registration statement on Form S-4 containing a preliminary proxy statement/prospectus, provide additional detail on the contemplated transaction, the structure of the combined company, and the treatment of existing securities. Through these filings, investors can review the legal terms, risk factors and corporate actions that shape the outlook for NVACR rights and the underlying SPAC.